Drug Channels

APRIL 1, 2024

Consider two apparently unrelated drug channel anomalies: In McKesson’s 2023 fiscal year, CVS bought $75 billion in pharmaceuticals from McKesson’s wholesale business—a jump of more than 35% compared with the previous year. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Pharmacy 98

Pharmacy Hospitals Pharmaceuticals Drugs 98

Drug Channels

OCTOBER 11, 2022

I am pleased to announce our new 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. examines how the Inflation Reduction Act could ultimately impact pharmaceutical wholesalers’ customers and business outlook.

Pharmaceuticals 74

Pharmaceuticals Biosimilars Licensing Licensing 74

Drug Channels

SEPTEMBER 11, 2024

P.S. Today’s article is adapted from Chapter 3 of DCI’s forthcoming 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , which will be available to preorder next week at special introductory pricing. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Pharmaceuticals Production 52

Drug Channels

DECEMBER 5, 2023

Consider two apparently unrelated drug channel anomalies: In McKesson’s 2023 fiscal year, CVS bought $75 billion in pharmaceuticals from McKesson’s wholesale business—a jump of more than 35% compared with the previous year. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. to 1:30 p.m. Click here to learn more and sign up.

Pharmacy 98

Pharmacy Drugs Hospitals Pharmaceuticals 98

Drug Channels

OCTOBER 2, 2024

This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Click here to see the original post from June 2024. Fein, Ph.D.,

52

52

Drug Channels

FEBRUARY 7, 2024

Tomorrow, we’ll be treated to a Senate show trial featuring pharmaceutical company executives. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. healthcare expenditures. Will drug pricing flat earthers (#DPFE) ever acknowledge the data?

Pharmaceutical Companies 98

Pharmaceutical Companies Drugs Pharmaceuticals Trials 98

Drug Channels

FEBRUARY 24, 2023

Matt shares three key findings from CareMetx’s exclusive new survey on patient support services for specialty pharmaceuticals. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. To learn more, download CareMetx’s free 2022 Report - Patient Services Trends. Read on for Matt’s insights. d/b/a Drug Channels Institute.

Pharmaceuticals 98

Pharmaceuticals Drugs 98

Drug Channels

DECEMBER 14, 2023

Future Trends for Buy-and-Bill Channels) of our new our 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , now available to download at special launch pricing. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. FYI: Today’s article is adapted from Section 6.3. d/b/a Drug Channels Institute.

Pharmaceuticals 52

Pharmaceuticals Hospitals Drugs 52

Drug Channels

MAY 18, 2023

To learn more about Phil’s access and commercialization solutions, download their free whitepaper, Modernize the Patient Access Experience: Transform Your Pharmaceutical Brand. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. You can also visit [link]. Read on for Patrick’s insights. d/b/a Drug Channels Institute.

Drugs 98

Drugs Pharmaceuticals 98

Drug Channels

JULY 13, 2023

Today’s guest post comes from Josh Bliss, SVP of Customer Acquisition and Head of Pharma Solutions at SingleCare Josh discusses the challenges that pharmaceutical manufacturers face connecting with consumers who could benefit from patient financial support programs. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Pharmaceuticals 98

Pharmaceuticals Marketing Drugs 98

Drug Channels

OCTOBER 5, 2021

I am pleased to announce our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. Copyright © 2006-2021 Pembroke Consulting, Inc. So, you can find out what your customers, partners, and competitors are reading.

Pharmaceuticals 75

Pharmaceuticals Biosimilars Licensing Licensing 75

Drug Channels

JUNE 7, 2024

Nasir highlights manufacturers' top objectives and vendor metrics from CareMetx’s recent survey of leaders and decision makers in the specialty pharmaceutical industry. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for Nasir’s insights.

Pharmaceuticals 52

Pharmaceuticals Production Drugs 52

Drug Channels

OCTOBER 2, 2023

This week, I’m rerunning some popular posts while I put the finishing touches on DCI's new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Click here to see the original post from May 2023. d/b/a Drug Channels Institute.

Pharmacy 97

Pharmacy Pharmaceuticals Marketing Drugs 97

Drug Channels

SEPTEMBER 12, 2023

On October 10, 2023, Drug Channels Institute will release 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. pharmaceutical distribution industry. Copyright © 2006-2023 Pembroke Consulting, Inc. Click here to email us if you would like to pay by corporate purchase order or check.

Pharmaceuticals 52

Pharmaceuticals Pharmacy Biosimilars Licensing 52

Drug Channels

OCTOBER 4, 2023

This week, I’m rerunning some popular posts while I put the finishing touches on DCI's new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Pharmaceuticals 98

Pharmaceuticals Drugs 98

Drug Channels

APRIL 8, 2024

We intend to bring together people from the entire drug channel: pharmaceutical manufacturers, pharmacy benefit managers (PBMs), health plans, insurers, and plan sponsors, wholesalers and distributors, pharmacies, providers, buying groups, government officials, and more. We will also have a very limited number of sponsors.

Pharmacy 97

Pharmacy Drugs Government Pharmaceuticals 97

Drug Channels

OCTOBER 1, 2022

Kylie explains how new ways of harnessing patient data can transform the way pharmaceutical companies interact with patients and providers—and ultimately help improve adherence. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Click here to learn about the ConnectiveRx Enterprise Data Platform. Read on for Kylie’s insights.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceuticals Production Drugs 98

Drug Channels

OCTOBER 1, 2022

Kylie explains how new ways of harnessing patient data can transform the way pharmaceutical companies interact with patients and providers—and ultimately help improve adherence. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Click here to learn about the ConnectiveRx Enterprise Data Platform. Read on for Kylie’s insights.

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceuticals Production Drugs 96

Drug Discovery World

MAY 17, 2023

NIAID has funded the discovery and development of HOPO 14-1 since 2006. The active pharmaceutical ingredient in the drug is called 3,4,3-LI(1,2-HOPO). These studies also have found that HOPO 14-1 is up to 100 times more effective than DTPA at binding and removing these radioactive elements.

Trials 130

Trials International Clinical Trials Drugs 130

Drug Channels

OCTOBER 10, 2023

I am pleased to announce our new 2023–24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. we analyze the IRA’s likely consequences for wholesalers and the overall pharmaceutical business. In Subsection 6.5.1.,

Pharmaceuticals 40

Pharmaceuticals Specialty Pharmacies Pharmacy Biosimilars 40

Drug Channels

AUGUST 8, 2023

Below, I include links to publicly available comments from a diverse range of stakeholders, including 340B Health, the American Hospital Association, Biotechnology Innovation Organization, Community Oncology Alliance, National Association of Community Health Centers, and Pharmaceutical Research and Manufacturers of America.

Pharmacy 96

Pharmacy Hospitals Drugs Pharmaceuticals 96

Drug Channels

JUNE 2, 2022

Bonnie describes how pharmaceutical care would benefit from standard medical record identification. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Today’s guest post comes from Bonnie Briggs, Associate Director of Clinical Effectiveness at Wolters Kluwer, Health. Read on for Bonnie’s insights.

Pharmaceuticals 98

Pharmaceuticals Drugs 98

Drug Channels

DECEMBER 13, 2023

FYI: The material in today’s article is adapted from Chapter 3 of our forthcoming 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , now available to preorder at special introductory pricing. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Pharmaceuticals Production 98

Drug Channels

SEPTEMBER 13, 2023

FYI: The material in today’s article is adapted from Chapter 3 of our forthcoming 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , now available to preorder at special introductory pricing. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Pharmaceuticals Production 97

Drug Channels

SEPTEMBER 23, 2024

© 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. The content of Sponsored Posts does not necessarily reflect the views of HMP Omnimedia, LLC, Drug Channels Institute, its parent company, or any of its employees. All rights reserved. This Feed is for personal non-commercial use only.

Compliance 52

Compliance Pharmaceuticals Government Marketing 52

Drug Channels

AUGUST 12, 2022

Divya then explains how GoodRx partners with pharmaceutical companies to improve cost transparency and communication between patients and providers. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Click here to learn more about how GoodRx helps brand teams engage providers in specific specialties.

Pharmaceutical Companies 96

Pharmaceutical Companies Pharmaceuticals Research Drugs 96

Drug Channels

JULY 29, 2022

Note that the forecasts below did not account for policy changes that could further reduce pharmaceuticals' share of U.S. Thus, the government actuaries expect that pharmaceuticals will not be the key driver of U.S. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. healthcare spending. spending on healthcare.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Drug Channels

APRIL 8, 2022

Michael discusses patient support challenges that are unique to specialty-lite pharmaceuticals. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Today’s guest post comes from Michael Carr, CoAssist Group Vice President at AssistRx. Read on for Michael’s insights. d/b/a Drug Channels Institute.

Specialty Pharmacies 96

Specialty Pharmacies Pharmacy Production Pharmaceuticals 96

Drug Channels

SEPTEMBER 21, 2022

FYI: The material in today’s article is adapted from Chapter 3 of our forthcoming 2022-23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , now available to preorder at special introductory pricing. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Specialty Pharmacies 97

Specialty Pharmacies Hospitals Pharmacy Pharmaceuticals 97

Drug Channels

OCTOBER 13, 2022

pharmaceutical distribution, payment, and reimbursement system. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. I conservatively estimate that I’ve created about 1,374,613 slides during my career. But there are two slides that people seem to appreciate the most. drug channels. Khan has other ideas about these companies.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 98

Drug Channels

JULY 23, 2024

It’s time for Drug Channels ’ annual update on pricing at the largest pharmaceutical manufacturers. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. You can find links to each company’s data below. Insulin has been the first to deflate—and the Humira biosimilar market may be next.

Biosimilars 52

Biosimilars Pharmaceuticals Production Marketing 52

Drug Channels

APRIL 11, 2022

The content-rich agenda boasts an incredible speaking faculty joining the event, including experts from Ingenus Pharmaceuticals, McKesson, Hikma Pharmaceuticals, Cardinal Health, Teva Pharmaceuticals, Tolmar Pharmaceuticals, FFF Enterprises, IntegriChain, Mallinckrodt Pharmaceuticals, UCB Pharma, Chronicled, Fresenius-Kabi USA, Premier Inc.,

Science 97

Science Pharmaceuticals Drugs 97

Drug Channels

MAY 24, 2023

In recent years, each of these companies has launched new group purchasing organizations (GPOs) to further consolidate the number of covered lives in rebate negotiations with pharmaceutical manufacturers. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. to 1:30 p.m. Click here to learn more and register.

Pharmacy 98

Pharmacy Pharmaceuticals Marketing Drugs 98

Drug Channels

OCTOBER 18, 2022

As we explain below, this accelerating adoption also boosts profits for pharmaceutical wholesalers and specialty distributors—particularly when these channel participants can influence which biosimilar version a provider utilizes. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. drug distribution.

Biosimilars 97

Biosimilars Drugs Pharmaceuticals Production 97

Drug Channels

SEPTEMBER 3, 2024

© 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Register Today. Download the brochure. The content of Sponsored Posts does not necessarily reflect the views of HMP Omnimedia, LLC, Drug Channels Institute, its parent company, or any of its employees. All rights reserved.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Government Regulations 52

Drug Channels

JULY 16, 2024

PBMs’ negotiating leverage against pharmaceutical manufacturers has been a key factor inflating the gross-to-net bubble —the ever-growing dollar gap between sales at brand-name drugs’ list prices and their sales at net prices after rebates, discounts, and other reductions. Pharmacies and Pharmacy Benefit Managers. All rights reserved.

Pharmacy 52

Pharmacy Pharmaceuticals Production Drugs 52

Drug Channels

APRIL 21, 2022

This post is adapted from Chapter 3 of our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. The video is excerpted from my recent Drug Channels Update: Buy-and-Bill Trends video webinar. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Drugs Pharmaceuticals Hospitals 98